Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382051330> ?p ?o ?g. }
- W4382051330 endingPage "102774" @default.
- W4382051330 startingPage "102774" @default.
- W4382051330 abstract "Babesia gibsoni is mainly transmitted by hard ticks of the genus Rhipicephalus (R. sanguineus) and Haemaphysalis (H. longicornis), and causes canine babesiosis. Clinical manifestations of B. gibsoni infection include fever, hemoglobinemia, hemoglobinuria, and progressive anemia. Traditional antibabesial therapy, such as imidocarb dipropionate or diminazene aceturate, can only alleviate severe clinical manifestations and cannot eliminate parasites in the host. Food and Drug Administration (FDA)-approved drugs are a solid starting point for researching novel therapy strategies for canine babesiosis. In this work, we screened 640 FDA-approved drugs against the growth of B. gibsoni in vitro. Among them, 13 compounds (at 10 μM) exhibited high growth inhibition (>60%), and two compounds, namely idarubicin hydrochloride (idamycin) and vorinostat, were chosen for further investigation. The half-maximal inhibitory concentration (IC50) values of idamycin and vorinostat were determined to be 0.044 ± 0.008 μM and 0.591 ± 0.107 μM, respectively. Viability results indicated that a concentration of 4 × IC50 of vorinostat prevented the regrowth of treated B. gibsoni, whereas parasites treated with 4 × IC50 concentration of idamycin remained viable. The B. gibsoni parasites treated with vorinostat exhibited degeneration within erythrocytes and merozoites, in contrast to the oval or signet-ring shape of normal B. gibsoni parasites. In conclusion, FDA-approved drugs offer a valuable platform for drug repositioning in antibabesiosis research. Particularly, vorinostat demonstrated promising inhibitory effects against B. gibsoni in vitro, and further studies on vorinostat are necessary to elucidate its mechanism as a novel treatment in infected animal models." @default.
- W4382051330 created "2023-06-27" @default.
- W4382051330 creator A5001225549 @default.
- W4382051330 creator A5006251599 @default.
- W4382051330 creator A5018431153 @default.
- W4382051330 creator A5045049738 @default.
- W4382051330 creator A5051857786 @default.
- W4382051330 creator A5068677420 @default.
- W4382051330 creator A5081453356 @default.
- W4382051330 creator A5083127877 @default.
- W4382051330 creator A5086275760 @default.
- W4382051330 creator A5088825137 @default.
- W4382051330 date "2023-10-01" @default.
- W4382051330 modified "2023-10-15" @default.
- W4382051330 title "In vitro screening of compounds from the Food and Drug Administration-approved library identifies anti-Babesia gibsoni activity of idarubicin hydrochloride and vorinostat" @default.
- W4382051330 cites W1976960897 @default.
- W4382051330 cites W2012631080 @default.
- W4382051330 cites W2041580058 @default.
- W4382051330 cites W2048214726 @default.
- W4382051330 cites W2093221196 @default.
- W4382051330 cites W2095236461 @default.
- W4382051330 cites W2149379768 @default.
- W4382051330 cites W2168923584 @default.
- W4382051330 cites W2177647997 @default.
- W4382051330 cites W2284824076 @default.
- W4382051330 cites W2418163421 @default.
- W4382051330 cites W2565928714 @default.
- W4382051330 cites W2791910957 @default.
- W4382051330 cites W2796480630 @default.
- W4382051330 cites W2839200018 @default.
- W4382051330 cites W2885239461 @default.
- W4382051330 cites W2942813814 @default.
- W4382051330 cites W2999301017 @default.
- W4382051330 cites W2999560038 @default.
- W4382051330 cites W3011638072 @default.
- W4382051330 cites W3024230992 @default.
- W4382051330 cites W3035026987 @default.
- W4382051330 cites W3188319732 @default.
- W4382051330 cites W4220738255 @default.
- W4382051330 cites W4283761030 @default.
- W4382051330 doi "https://doi.org/10.1016/j.parint.2023.102774" @default.
- W4382051330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37380124" @default.
- W4382051330 hasPublicationYear "2023" @default.
- W4382051330 type Work @default.
- W4382051330 citedByCount "0" @default.
- W4382051330 crossrefType "journal-article" @default.
- W4382051330 hasAuthorship W4382051330A5001225549 @default.
- W4382051330 hasAuthorship W4382051330A5006251599 @default.
- W4382051330 hasAuthorship W4382051330A5018431153 @default.
- W4382051330 hasAuthorship W4382051330A5045049738 @default.
- W4382051330 hasAuthorship W4382051330A5051857786 @default.
- W4382051330 hasAuthorship W4382051330A5068677420 @default.
- W4382051330 hasAuthorship W4382051330A5081453356 @default.
- W4382051330 hasAuthorship W4382051330A5083127877 @default.
- W4382051330 hasAuthorship W4382051330A5086275760 @default.
- W4382051330 hasAuthorship W4382051330A5088825137 @default.
- W4382051330 hasConcept C104317684 @default.
- W4382051330 hasConcept C159047783 @default.
- W4382051330 hasConcept C2776262904 @default.
- W4382051330 hasConcept C2777459041 @default.
- W4382051330 hasConcept C2778143080 @default.
- W4382051330 hasConcept C2778145968 @default.
- W4382051330 hasConcept C2778305200 @default.
- W4382051330 hasConcept C2780035454 @default.
- W4382051330 hasConcept C55493867 @default.
- W4382051330 hasConcept C64927066 @default.
- W4382051330 hasConcept C71924100 @default.
- W4382051330 hasConcept C86803240 @default.
- W4382051330 hasConcept C98274493 @default.
- W4382051330 hasConceptScore W4382051330C104317684 @default.
- W4382051330 hasConceptScore W4382051330C159047783 @default.
- W4382051330 hasConceptScore W4382051330C2776262904 @default.
- W4382051330 hasConceptScore W4382051330C2777459041 @default.
- W4382051330 hasConceptScore W4382051330C2778143080 @default.
- W4382051330 hasConceptScore W4382051330C2778145968 @default.
- W4382051330 hasConceptScore W4382051330C2778305200 @default.
- W4382051330 hasConceptScore W4382051330C2780035454 @default.
- W4382051330 hasConceptScore W4382051330C55493867 @default.
- W4382051330 hasConceptScore W4382051330C64927066 @default.
- W4382051330 hasConceptScore W4382051330C71924100 @default.
- W4382051330 hasConceptScore W4382051330C86803240 @default.
- W4382051330 hasConceptScore W4382051330C98274493 @default.
- W4382051330 hasFunder F4320320912 @default.
- W4382051330 hasFunder F4320322266 @default.
- W4382051330 hasFunder F4320334764 @default.
- W4382051330 hasLocation W43820513301 @default.
- W4382051330 hasLocation W43820513302 @default.
- W4382051330 hasOpenAccess W4382051330 @default.
- W4382051330 hasPrimaryLocation W43820513301 @default.
- W4382051330 hasRelatedWork W1185130599 @default.
- W4382051330 hasRelatedWork W2075202252 @default.
- W4382051330 hasRelatedWork W2086155422 @default.
- W4382051330 hasRelatedWork W2160014586 @default.
- W4382051330 hasRelatedWork W2181471054 @default.
- W4382051330 hasRelatedWork W2225639950 @default.
- W4382051330 hasRelatedWork W2410681106 @default.
- W4382051330 hasRelatedWork W2553614208 @default.
- W4382051330 hasRelatedWork W3145572397 @default.